• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从临床实践研究数据库(CPRD)招募慢性阻塞性肺疾病(COPD)患者进行研究。

Recruitment of patients with Chronic Obstructive Pulmonary Disease (COPD) from the Clinical Practice Research Datalink (CPRD) for research.

机构信息

Department of Respiratory Epidemiology, Occupational Medicine & Public Health, Imperial College London, National Heart and Lung Institute, London, UK.

Clinical Practice Research Datalink, Medicines and Healthcare products Regulatory Agency, London, UK.

出版信息

NPJ Prim Care Respir Med. 2018 Jun 19;28(1):21. doi: 10.1038/s41533-018-0089-3.

DOI:10.1038/s41533-018-0089-3
PMID:29921879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6008416/
Abstract

Databases of electronic health records (EHR) are not only a valuable source of data for health research but have also recently been used as a medium through which potential study participants can be screened, located and approached to take part in research. The aim was to assess whether it is feasible and practical to screen, locate and approach patients to take part in research through the Clinical Practice Research Datalink (CPRD). This is a cohort study in primary care. The CPRD anonymised EHR database was searched to screen patients with Chronic Obstructive Pulmonary Disease (COPD) to take part in a research study. The potential participants were contacted via their General Practitioner (GP) who confirmed their eligibility. Eighty two practices across Greater London were invited to the study. Twenty-six (31.7%) practices consented to participate resulting in a pre-screened list of 988 patients. Of these, 632 (63.7%) were confirmed as eligible following the GP review. Two hundred twenty seven (36%) response forms were received by the study team; 79 (34.8%) responded 'yes' (i.e., they wanted to be contacted by the research assistant for more information and to talk about enrolling in the study), and 148 (65.2%) declined participation. This study has shown that it is possible to use EHR databases such as CPRD to screen, locate and recruit participants for research. This method provides access to a cohort of patients while minimising input needed by GPs and allows researchers to examine healthcare usage and disease burden in more detail and in real-life settings.

摘要

电子健康记录 (EHR) 数据库不仅是健康研究的宝贵数据源,最近也被用作筛选、定位和联系潜在研究参与者以参与研究的媒介。目的是评估通过临床实践研究数据链 (CPRD) 筛选、定位和联系患者参与研究是否可行和实际。这是一项初级保健中的队列研究。在 CPRD 匿名 EHR 数据库中搜索患有慢性阻塞性肺疾病 (COPD) 的患者,以参加研究。通过他们的全科医生 (GP) 联系潜在参与者,以确认他们是否符合条件。邀请了大伦敦地区的 82 家诊所参加该研究。26 家 (31.7%) 诊所同意参与,从而产生了一份 988 名患者的预筛选名单。在这些患者中,632 名 (63.7%) 经 GP 审查后被确认为符合条件。研究小组收到了 227 份 (36%) 的回复表;79 份 (34.8%) 回复“是”(即他们希望被研究助理联系以获取更多信息并讨论参与研究),148 份 (65.2%) 拒绝参与。这项研究表明,使用 CPRD 等 EHR 数据库筛选、定位和招募研究参与者是可行的。这种方法可以让研究人员接触到患者队列,同时最大限度地减少全科医生的投入,并允许研究人员更详细地在实际环境中检查医疗保健的使用情况和疾病负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a018/6008416/e9eb4077e15a/41533_2018_89_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a018/6008416/b165cdb8c63d/41533_2018_89_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a018/6008416/706db433d1a1/41533_2018_89_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a018/6008416/e9eb4077e15a/41533_2018_89_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a018/6008416/b165cdb8c63d/41533_2018_89_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a018/6008416/706db433d1a1/41533_2018_89_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a018/6008416/e9eb4077e15a/41533_2018_89_Fig3_HTML.jpg

相似文献

1
Recruitment of patients with Chronic Obstructive Pulmonary Disease (COPD) from the Clinical Practice Research Datalink (CPRD) for research.从临床实践研究数据库(CPRD)招募慢性阻塞性肺疾病(COPD)患者进行研究。
NPJ Prim Care Respir Med. 2018 Jun 19;28(1):21. doi: 10.1038/s41533-018-0089-3.
2
Feasibility of using Clinical Practice Research Datalink data to identify patients with chronic obstructive pulmonary disease to enrol into real-world trials.利用临床实践研究数据库数据识别慢性阻塞性肺疾病患者以纳入真实世界研究的可行性。
Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):472-481. doi: 10.1002/pds.5188. Epub 2021 Jan 9.
3
Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD).慢性阻塞性肺疾病记录在临床实践研究数据链(CPRD-GOLD)中的验证。
BMJ Open. 2014 Jul 23;4(7):e005540. doi: 10.1136/bmjopen-2014-005540.
4
Varenicline versus nicotine replacement therapy for long-term smoking cessation: an observational study using the Clinical Practice Research Datalink.伐尼克兰与尼古丁替代疗法用于长期戒烟:一项使用临床实践研究数据库的观察性研究。
Health Technol Assess. 2020 Feb;24(9):1-46. doi: 10.3310/hta24090.
5
What happens between first symptoms and first acute exacerbation of COPD - observational study of routine data and patient survey.COPD 首次症状与首次急性加重之间的情况 - 常规数据和患者调查的观察性研究。
Health Soc Care Deliv Res. 2024 Oct;12(43):1-80. doi: 10.3310/CGTR6370.
6
Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications.临床实践研究数据链接(CPRD)初级保健数据与其他健康相关患者数据的记录链接方法:概述及意义。
Eur J Epidemiol. 2019 Jan;34(1):91-99. doi: 10.1007/s10654-018-0442-4. Epub 2018 Sep 15.
7
The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials.利用常规收集的电子记录进行务实的即时随机试验的机遇与挑战:两项示例试验的评估
Health Technol Assess. 2014 Jul;18(43):1-146. doi: 10.3310/hta18430.
8
A Harmonised Approach to Curating Research-Ready Datasets for Asthma, Chronic Obstructive Pulmonary Disease (COPD) and Interstitial Lung Disease (ILD) in England, Wales and Scotland Using Clinical Practice Research Datalink (CPRD), Secure Anonymised Information Linkage (SAIL) Databank and DataLoch.采用临床实践研究数据链(CPRD)、安全匿名信息链接(SAIL)数据库和DataLoch,在英格兰、威尔士和苏格兰为哮喘、慢性阻塞性肺疾病(COPD)和间质性肺疾病(ILD)策划研究就绪数据集的统一方法。
Clin Epidemiol. 2024 Apr 4;16:235-247. doi: 10.2147/CLEP.S437937. eCollection 2024.
9
Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results.慢性阻塞性肺疾病药物治疗:一项历史非干预性队列研究,与 RCT 结果相验证。
Health Technol Assess. 2021 Aug;25(51):1-70. doi: 10.3310/hta25510.
10
Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD).评估慢性阻塞性肺疾病(COPD)GOLD 组 A 或 B 患者中吸入皮质类固醇不合理处方相关的医疗资源使用情况:一项使用临床实践研究数据库(CPRD)的观察性研究。
Respir Res. 2018 Apr 11;19(1):63. doi: 10.1186/s12931-018-0767-2.

引用本文的文献

1
Resilience and health-related quality of life in patients with pulmonary diseases receiving ambulatory oxygen therapy - 24-month follow-up results.接受门诊氧疗的肺部疾病患者的恢复力与健康相关生活质量——24个月随访结果
BMC Pulm Med. 2025 Jul 4;25(1):326. doi: 10.1186/s12890-025-03778-8.
2
A machine learning framework for short-term prediction of chronic obstructive pulmonary disease exacerbations using personal air quality monitors and lifestyle data.一种使用个人空气质量监测器和生活方式数据对慢性阻塞性肺疾病急性加重进行短期预测的机器学习框架。
Sci Rep. 2025 Jan 18;15(1):2385. doi: 10.1038/s41598-024-85089-2.
3
Using routine primary care data in research: (in)efficient case studies and perspectives from the Asthma UK Centre for Applied Research.

本文引用的文献

1
Linking e-health records, patient-reported symptoms and environmental exposure data to characterise and model COPD exacerbations: protocol for the COPE study.连接电子健康记录、患者报告的症状和环境暴露数据以表征和模拟慢性阻塞性肺疾病(COPD)急性加重:COPE研究方案
BMJ Open. 2016 Jul 13;6(7):e011330. doi: 10.1136/bmjopen-2016-011330.
2
The Inaccuracy of Patient Recall for COPD Exacerbation Rate Estimation and Its Implications: Results from Central Adjudication.患者对 COPD 加重率估计的回忆不准确及其影响:来自中心审查的结果。
Chest. 2016 Oct;150(4):860-868. doi: 10.1016/j.chest.2016.06.031. Epub 2016 Aug 26.
3
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.
在研究中使用常规初级保健数据:(无)效率案例研究及英国哮喘应用研究中心的观点
BMJ Health Care Inform. 2025 Jan 9;32(1):e101134. doi: 10.1136/bmjhci-2024-101134.
4
Air pollution and respiratory health in patients with COPD: should we focus on indoor or outdoor sources?空气污染与 COPD 患者的呼吸健康:我们应关注室内还是室外污染源?
Thorax. 2024 Nov 14;79(12):1116-1123. doi: 10.1136/thorax-2024-221874.
5
Public and patient perspectives on the use of clinical and administrative health data to identify and contact people at risk of future illness-The case of chronic kidney disease.公众和患者对利用临床和行政健康数据来识别和联系未来有患病风险的人的看法——以慢性肾脏病为例。
PLoS One. 2024 Mar 1;19(3):e0298382. doi: 10.1371/journal.pone.0298382. eCollection 2024.
6
Use of routine healthcare data in randomised implementation trials: a methodological mixed-methods systematic review.在随机实施试验中使用常规医疗保健数据:一种方法学混合方法系统评价。
Implement Sci. 2023 Oct 2;18(1):47. doi: 10.1186/s13012-023-01300-4.
7
Early detection of COPD patients' symptoms with personal environmental sensors: a remote sensing framework using probabilistic latent component analysis with linear dynamic systems.使用个人环境传感器早期检测慢性阻塞性肺疾病患者的症状:一种基于线性动态系统的概率潜在成分分析的遥感框架。
Neural Comput Appl. 2023;35(23):17247-17265. doi: 10.1007/s00521-023-08554-5. Epub 2023 Apr 30.
8
Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap.哮喘、COPD 或哮喘-COPD 重叠患者中吸入β2-激动剂与肺炎相关的全因死亡率或住院风险。
Respir Res. 2022 Dec 20;23(1):364. doi: 10.1186/s12931-022-02295-0.
9
Association between Inhaled β-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study.吸入β-激动剂与主要不良心血管事件风险的关联:基于人群的巢式病例对照研究。
Int J Chron Obstruct Pulmon Dis. 2022 May 20;17:1205-1217. doi: 10.2147/COPD.S358927. eCollection 2022.
10
Realising the full potential of data-enabled trials in the UK: a call for action.挖掘英国数据驱动型试验的全部潜力:行动呼吁。
BMJ Open. 2021 Jun 16;11(6):e043906. doi: 10.1136/bmjopen-2020-043906.
茚达特罗格隆溴铵与沙美特罗氟替卡松治疗 COPD。
N Engl J Med. 2016 Jun 9;374(23):2222-34. doi: 10.1056/NEJMoa1516385. Epub 2016 May 15.
4
Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records.英国初级医疗电子健康记录中慢性阻塞性肺疾病急性加重记录的验证
PLoS One. 2016 Mar 9;11(3):e0151357. doi: 10.1371/journal.pone.0151357. eCollection 2016.
5
The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in chronic obstructive pulmonary disease.索尔福德肺部研究方案:一项针对慢性阻塞性肺疾病的实用、随机、III期真实世界有效性试验。
Respir Res. 2015 Sep 4;16(1):101. doi: 10.1186/s12931-015-0267-6.
6
Data Resource Profile: Clinical Practice Research Datalink (CPRD).数据资源简介:临床实践研究数据链(CPRD)
Int J Epidemiol. 2015 Jun;44(3):827-36. doi: 10.1093/ije/dyv098. Epub 2015 Jun 6.
7
One-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD.酒石酸阿福特罗用于中重度慢性阻塞性肺疾病患者的一年安全性和有效性研究。
Chest. 2014 Dec;146(6):1531-1542. doi: 10.1378/chest.14-0117.
8
Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD).慢性阻塞性肺疾病记录在临床实践研究数据链(CPRD-GOLD)中的验证。
BMJ Open. 2014 Jul 23;4(7):e005540. doi: 10.1136/bmjopen-2014-005540.
9
Preventing and lessening exacerbations of asthma in school-age children associated with a new term (PLEASANT): study protocol for a cluster randomised control trial.预防和减轻学龄儿童与新学期相关的哮喘加重(PLEASANT):一项整群随机对照试验的研究方案
Trials. 2013 Sep 16;14:297. doi: 10.1186/1745-6215-14-297.
10
SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink.SLCO1B1 基因变异与他汀类药物引起的肌病相关:使用临床实践研究数据库的概念验证研究。
Clin Pharmacol Ther. 2013 Dec;94(6):695-701. doi: 10.1038/clpt.2013.161. Epub 2013 Aug 13.